Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Lactobacillus helveticus is a probiotic bacterium commonly used in the fermentation of dairy products. In recent years, interest has grown in its potential therapeutic role in managing Irritable Bowel Syndrome (IBS). The rationale for using L. helveticus in IBS stems from its ability to modulate the gut microbiota, enhance the gut barrier, and exert anti-inflammatory effects. Several clinical studies have evaluated the effect of L. helveticus, often in combination with other probiotic strains, on IBS symptoms. For example, the combination of L. helveticus R0052 and Bifidobacterium longum R0175 has been shown in randomized controlled trials to reduce abdominal pain, bloating, and improve quality of life in IBS patients compared to placebo. The mechanisms proposed include modulation of the gut-brain axis, reduction of visceral hypersensitivity, and improvement of intestinal permeability.

However, while these findings are promising, the evidence is not yet conclusive. Many studies use mixed probiotic formulations, making it difficult to attribute effects solely to L. helveticus. The strain specificity and variability in study designs also limit generalizability. The overall quality of evidence is moderate, justifying a rating of 3 out of 5. More large-scale, well-controlled clinical trials are needed to establish the precise efficacy and optimal use of L. helveticus for IBS. Nevertheless, there is a growing scientific basis for its use, and it is considered a plausible adjunct in the management of IBS symptoms.

More about lactobacillus helveticus
More about Irritable Bowel Syndrome

Other ingredients used for Irritable Bowel Syndrome

Other health conditions supported by lactobacillus helveticus

Products containing lactobacillus helveticus

Integrative Therapeutics Blue Heron
Integrative Therapeutics Nutrivitamin No-Iron
Pure Encapsulations ProbioMood 3 Billion